BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 November 2006

Br J Ophthalmol. Published Online First: 6 July 2006. doi:10.1136/bjo.2006.093393
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
bjo.2006.093393v1
90/11/1404    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by knudsen, L. l
Right arrow Articles by Gorst-Rasmussen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by knudsen, L. l
Right arrow Articles by Gorst-Rasmussen, A.

Clinical science - Extended reports

The North Jutland County Diabetic Retinopathy Study Population Characteristics

Lars l knudsen 1*, Hans-Henrik Lervang 2, Søren Lundbye-Christensen 3 and Anders Gorst-Rasmussen 4

1 Department of Ophthalmology, Aalborg Sygehus Syd, Denmark, Denmark
2 Department of internal medicine, Aalborg Sygehus South, Denmark
3 Department of Mathematical Sciences, Aalborg University, Denmark
4 Department of Mathematical sciences, Aalborg University, Denmark

* To whom correspondence should be addressed. E-mail: u19204{at}aas.nja.dk.

Accepted 10 April 2006


*  Abstract

Aim: Several population based studies have reported blood glucose levels and blood pressure to be risk factors for the development of diabetic retinopathy. These studies were initiated more than two decades ago and may therefore reflect the treatment and population composition of a previous era suggesting new studies of the present diabetic population.

Methods: This cross-section study included 656 type 1 and 328 type 2 diabetic subjects. Crude prevalence rates for proliferative diabetic retinopathy, clinically significant macular oedema and several specific retinal lesions were assessed together with their association to a simplified and internationally approved retinal grading.

Results: The point prevalence of proliferative retinopathy was found to be 0.8 % and 0.3 % for type 1 and type 2 diabetes. Equivalent prevalence rates for clinically significant macular oedema were 7.9 % and 12.8 %, respectively. The most frequently occurring retinal manifestations were found increased in number up to retinopathy level 3 followed by decrease.

Conclusion: The point prevalence of proliferative retinopathy is lower than that of previous studies while it is increased for clinically significant macular oedema. These data suggest different risk factors for these clinical entities.





This article has been cited by other articles:


Home page
Diabetes CareHome page
J. H. Vallance, P. J. Wilson, G. P. Leese, R. McAlpine, C. J. MacEwen, and J. D. Ellis
Diabetic Retinopathy: More Patients, Less Laser: A longitudinal population-based study in Tayside, Scotland
Diabetes Care, June 1, 2008; 31(6): 1126 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
L L Knudsen, H-H Lervang, S Lundbye-Christensen, and A Gorst-Rasmussen
The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema
Br. J. Ophthalmol., December 1, 2007; 91(12): 1593 - 1595.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.